Arecor Therapeutics (AREC)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 68.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 199.00
  • 52 Week Low: 68.50
  • Currency: UK Pounds
  • Shares Issued: 37.76m
  • Volume: 15,000
  • Market Cap: £25.86m
  • Beta: 0.08

Latest Trades

Time Price Volume Value Buy/Sell Type
20-Sep-2024 14:53 69.49p 7,500 £5,212 Buy O
20-Sep-2024 14:48 69.49p 2,500 £1,737 Buy O
20-Sep-2024 14:13 69.49p 5,000 £3,474 Buy O

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

AREC Market Data

Currency UK Pounds
Share Price 68.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 199.00
52 Week Low 68.50
Volume 15,000
Shares Issued 37.76m
Market Cap £25.86m
Beta 0.08

AREC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
49.49% below the market average49.49% below the market average49.49% below the market average49.49% below the market average49.49% below the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average
Price Trend
88.67% below the market average88.67% below the market average88.67% below the market average88.67% below the market average88.67% below the market average
79.59% below the sector average79.59% below the sector average79.59% below the sector average79.59% below the sector average79.59% below the sector average
Income Not Available
Growth
57.07% above the market average57.07% above the market average57.07% above the market average57.07% above the market average57.07% above the market average
63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average

AREC Dividends

No dividends found

Trades for 20-Sep-2024

Time Volume / Share Price
14:53 7,500 @ 69.49p
14:48 2,500 @ 69.49p
14:13 5,000 @ 69.49p

AREC Key Personnel

CEO Sarah Jennifer Howell

Top of Page